OKEP Oct'15

Is this your test? Login to manage it. If not, you can make an assessment just like it.

This is a non-interactive preview of the quiz content.

Name:

Territory:

Email Id:

Febuxostat is used to treat __________

(a) Hyperuricemia

(b) Gout

(d) None

Which of the following is Xanthine Oxidase inhibitor?

(a) Febuxostat

(b) Amlodipine

(d) Sirolimus

Where was this study conducted?

(a) North India

(b) Western India.

(d) South India

What was the serum uric acid level after 6 months of Febuxostat given patients?

(a) 5.2 ± 1.5

(b) 9.0 ± 2.0

(d) 32.6 ± 11.4

What was the Serum eGFR after 6 months of Febuxostat was given to patients?

(a) 31.5 ± 13.6

(b) 32.6 ± 11.4

(d) 28.2 ± 11.5

What was the dose of Febuxostat Drug?

(a) 40 mg

(b) 50 mg

(d) 30 mg

10.

The study showed that febuxostat in hyperuricemic patients with CKD_______________

(a) Decreases hyperuricemia

(b) Slows eGFR decline

(d) None

11.

What was the total duration of study?

(a) 18 months

(b) 12 months

(d) 24 months

12.

Eligible participants were patients of both sexes aged 18 to 65 years with eGFR of _______mL/min/1.73 m 2

(a) 30 to 60

(b) 15 to 60

(d) 45 to 60

Home Features Pricing FAQs Legal Sample Tests Build a Test Login/Sign Up